Abivax Publishes 2025 Financial Calendar
Portfolio Pulse from
Abivax, a clinical-stage biotechnology company, has published its 2025 financial communications calendar. Key dates include the release of the 2024 Annual Business and Financial Report on March 24, 2025, Q1 Financial Results on June 2, 2025, the Annual General Meeting on June 6, 2025, Half-Year Financial Report on August 11, 2025, and Q3 Financial Results on December 15, 2025.
January 28, 2025 | 7:45 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Abivax has announced its 2025 financial calendar, detailing key dates for financial reports and the Annual General Meeting. This provides investors with a timeline for upcoming financial disclosures.
The announcement of a financial calendar is a routine disclosure that provides transparency and allows investors to plan for upcoming financial reports. It does not directly impact the stock price but is important for investor relations.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100